Cardiac Catheters - Pipeline Review, 2015 Now Available at iData Insights Cardiac Catheters - Pipeline Review, 2015 Summary GlobalData's Medical Devices sector report, Cardiac Catheters - Pipeline Review, 2015" provides an overview of Cardiac Catheters currently in pipeline stage. The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Cardiac Catheters pipeline products. This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts. Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type. Scope - Extensive coverage of the Cardiac Catheters under development - The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities - The report reviews the major players involved in the development of Cardiac Catheters and list all their pipeline projects The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage - The report provides key clinical trial data of ongoing trials specific to pipeline products - Recent developments in the segment / industry Reasons to buy The report enables you to - - Formulate significant competitor information, analysis, and insights to improve R&D strategies - Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage - Identify and understand important and diverse types of Cardiac Catheters under development - Develop market-entry and market expansion strategies - Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline - Indepth analysis of the products current stage of development, territory and estimated launch date Browse Complete Report with TOC @ http://www.idatainsights.com/reports-landingpage.php?id=124145/cardiac-catheters-pipeline-review-2015 To Get Sample Copy of Report visit @ http http://www.idatainsights.com/reports-landingpage.php?id=124145/cardiac-catheters-pipeline-review-2015 Table of Contents 1 Table of Contents 1 Table of Contents 2 1.1 List of Tables 5 1.2 List of Figures 9 2 Introduction 10 2.1 Cardiac Catheters Overview 10 1
3 Products under Development 11 3.1 Cardiac Catheters - Pipeline Products by Stage of Development 11 3.2 Cardiac Catheters - Pipeline Products by Segment 12 3.3 Cardiac Catheters - Pipeline Products by Territory 13 3.4 Cardiac Catheters - Pipeline Products by Regulatory Path 14 3.5 Cardiac Catheters - Pipeline Products by Estimated Approval Date 15 3.6 Cardiac Catheters - Ongoing Clinical Trials 16 4 Cardiac Catheters - Pipeline Products under Development by Companies 17 4.1 Cardiac Catheters Companies - Pipeline Products by Stage of Development 17 4.2 Cardiac Catheters - Pipeline Products by Stage of Development 19 5 Cardiac Catheters Companies and Product Overview 21 5.1 AccuTherm Systems, Inc. Company Overview 21 5.1.1 AccuTherm Systems, Inc. Pipeline Products & Ongoing Clinical Trials Overview 21 5.2 Andain, Inc Company Overview 22 5.2.1 Andain, Inc Pipeline Products & Ongoing Clinical Trials Overview 22 5.3 AngioDynamics, Inc. Company Overview 23 5.3.1 AngioDynamics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 23 5.4 Balch Hill Medical Group Company Overview 25 5.4.1 Balch Hill Medical Group Pipeline Products & Ongoing Clinical Trials Overview 25 5.5 Bioheart, Inc. Company Overview 26 5.5.1 Bioheart, Inc. Pipeline Products & Ongoing Clinical Trials Overview 26 5.6 Boston Scientific Corporation Company Overview 31 5.6.1 Boston Scientific Corporation Pipeline Products & Ongoing Clinical Trials Overview 31 5.7 Boston TransTec, LLC Company Overview 36 5.7.1 Boston TransTec, LLC Pipeline Products & Ongoing Clinical Trials Overview 36 5.8 Cardiac Output Technologies, Inc. Company Overview 37 5.8.1 Cardiac Output Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview 37 5.9 Cardiovascular Systems, Inc. Company Overview 38
2
5.9.1 Cardiovascular Systems, Inc. Pipeline Products & Ongoing Clinical Trials Overview 38 5.10 Cordis Corporation Company Overview 42 5.10.1 Cordis Corporation Pipeline Products & Ongoing Clinical Trials Overview 42 5.11 CorNova, Inc. Company Overview 45 5.11.1 CorNova, Inc. Pipeline Products & Ongoing Clinical Trials Overview 45 5.12 Delft University of Technology Company Overview 49 5.12.1 Delft University of Technology Pipeline Products & Ongoing Clinical Trials Overview 49 5.13 Deliverance Ltd. Company Overview 52 5.13.1 Deliverance Ltd. Pipeline Products & Ongoing Clinical Trials Overview 52 5.14 EndoCross Ltd. Company Overview 53 5.14.1 EndoCross Ltd. Pipeline Products & Ongoing Clinical Trials Overview 53 5.15 EP Limited Company Overview 56 5.15.1 EP Limited Pipeline Products & Ongoing Clinical Trials Overview 56 5.16 Hadasit Medical Research Services & Development Ltd Company Overview 57 5.16.1 Hadasit Medical Research Services & Development Ltd Pipeline Products & Ongoing Clinical Trials Overview 57 5.17 Harvard University Company Overview 58 5.17.1 Harvard University Pipeline Products & Ongoing Clinical Trials Overview 58 5.18 MaRVis Technologies GmbH Company Overview 60 5.18.1 MaRVis Technologies GmbH Pipeline Products & Ongoing Clinical Trials Overview 60 5.19 Mayo Clinic Company Overview 61 5.19.1 Mayo Clinic Pipeline Products & Ongoing Clinical Trials Overview 61 5.20 Medeon Biodesign, Inc. Company Overview 62 5.20.1 Medeon Biodesign, Inc. Pipeline Products & Ongoing Clinical Trials Overview 62 5.21 Medical Device Investments, Inc. Company Overview 63 5.21.1 Medical Device Investments, Inc. Pipeline Products & Ongoing Clinical Trials Overview 63 5.22 Medikit Co., Ltd. Company Overview 65 5.22.1 Medikit Co., Ltd. Pipeline Products & Ongoing Clinical Trials Overview 65 5.23 Merit Medical Systems, Inc. Company Overview 69 3
5.23.1 Merit Medical Systems, Inc. Pipeline Products & Ongoing Clinical Trials Overview 69 5.24 MicroPort Scientific Corporation Company Overview 72 5.24.1 MicroPort Scientific Corporation Pipeline Products & Ongoing Clinical Trials Overview 72 5.25 Neovasc Inc. Company Overview 75 5.25.1 Neovasc Inc. Pipeline Products & Ongoing Clinical Trials Overview 75 5.26 Nesstent Ltd. Company Overview 77 5.26.1 Nesstent Ltd. Pipeline Products & Ongoing Clinical Trials Overview 77 5.27 NeuroInterventional Therapeutics, Inc. Company Overview 78 5.27.1 NeuroInterventional Therapeutics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 78 5.28 Northwestern University Company Overview 79 5.28.1 Northwestern University Pipeline Products & Ongoing Clinical Trials Overview 79 5.29 Perseus Biomed Ltd. Company Overview 80 5.29.1 Perseus Biomed Ltd. Pipeline Products & Ongoing Clinical Trials Overview 80 5.30 Pi-Cardia Ltd Company Overview 82 5.30.1 Pi-Cardia Ltd Pipeline Products & Ongoing Clinical Trials Overview 82 5.31 Pryor Medical Devices, Inc. Company Overview 83 5.31.1 Pryor Medical Devices, Inc. Pipeline Products & Ongoing Clinical Trials Overview 83 5.32 QualiMed Innovative Medizinprodukte GmbH Company Overview 84 5.32.1 QualiMed Innovative Medizinprodukte GmbH Pipeline Products & Ongoing Clinical Trials Overview 84 5.33 Rhythm Solutions Company Overview 85 5.33.1 Rhythm Solutions Pipeline Products & Ongoing Clinical Trials Overview 85 5.34 Therix Medical, Inc. Company Overview 86 5.34.1 Therix Medical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 86 5.35 Topspin Medical Inc. Company Overview 87 5.35.1 Topspin Medical Inc. Pipeline Products & Ongoing Clinical Trials Overview 87 5.36 TransCardiac Therapeutics, LLC Company Overview 91 5.36.1 TransCardiac Therapeutics, LLC Pipeline Products & Ongoing Clinical Trials Overview 91 5.37 Universite de Montreal Company Overview 92 4
5.37.1 Universite de Montreal Pipeline Products & Ongoing Clinical Trials Overview 92 5.38 University of California, San Francisco Company Overview 93 5.38.1 University of California, San Francisco Pipeline Products & Ongoing Clinical Trials Overview 93 5.39 University of Limerick Company Overview 94 5.39.1 University of Limerick Pipeline Products & Ongoing Clinical Trials Overview 94 5.40 Volcano Corporation Company Overview 95 5.40.1 Volcano Corporation Pipeline Products & Ongoing Clinical Trials Overview 95 5.41 Voyage Medical Company Overview 97 5.41.1 Voyage Medical Pipeline Products & Ongoing Clinical Trials Overview 97 6 Cardiac Catheters- Recent Developments 98 7 Appendix 243 7.1 Methodology 243 7.2 About GlobalData 245 7.3 Contact Us 246 7.4 Disclaimer 246 Read More http://www.idatainsights.com/reports-landing-page.php?id=124145/cardiac-catheterspipeline-review-2015 About Us: iData Insights which operates under Precision Research and Consulting Private Limited is a leading market research information aggregator and marketing research consulting firm. We conduct both primary and secondary research. Our work does not end with research it is also involved in distributing reports for different companies . We provide actionable recommendations and provide our expertise for business success today and tomorrow. It is our goal to be a partner to our clients in the exploration and discovery, and then be their guide in the implementation of changes that will make a difference to their bottom line. ContactUs: iData Insights Tel: 1-866-237-2965 Web: http://www.idatainsights.com Email: info@idatainsights.com About iData Insights We work around the clock until our clients are completely satisfied with their promised results. It is our mission to provide timely services coupled with acute client care to create a long-lasting relationship
5
with you. We deliver on our promise to provide results that are essential to the success of your company. We believe that by doing so, we will earn the trust of our clients for future projects.
6